First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co-development with Orano Med "Our presentations at AACR highlight the breadth of Molecular Partners' DARPin ...

After years of back and forth and more than a few complaints about the current configuration of Pittsfield's busiest roadway ...